Suboxone for Alcohol Use Disorder: What the Evidence Says

How Suboxone Works

Suboxone contains two active ingredients with distinct mechanisms. Buprenorphine is a partial opioid agonist — it activates opioid receptors but only partially, providing mild opioid effects that reduce withdrawal symptoms and cravings in opioid-dependent individuals. Naloxone is an opioid antagonist included to prevent misuse by injection. When taken sublingually (under the tongue) as directed, buprenorphine is absorbed and naloxone has minimal effect. The naloxone component is primarily a deterrent against intravenous misuse.

Why People Ask About Suboxone for Alcohol

The interest in Suboxone for alcohol stems from two observations. First, naloxone (one of Suboxone's components) is an opioid antagonist similar to naltrexone, which IS approved for alcohol treatment. Second, many people have co-occurring alcohol and opioid use disorders, and they may wonder if Suboxone can treat both conditions simultaneously. These are reasonable questions, but the pharmacology is more nuanced than it appears.

• •Naltrexone (approved for AUD) and naloxone (in Suboxone) are both opioid antagonists but differ significantly
• •Naltrexone has a long duration of action (24+ hours oral, 30 days injectable) making it suitable for daily treatment
• •Naloxone in Suboxone has poor oral/sublingual bioavailability — most of it never reaches the brain when taken as directed
• •Buprenorphine (the other component) actually activates opioid receptors, which could theoretically reinforce rather than discourage drinking

What the Research Shows

Current evidence does not support using Suboxone specifically for alcohol use disorder. The naloxone in Suboxone has very low bioavailability when taken sublingually (only about 3-5% reaches systemic circulation), meaning it provides negligible opioid receptor blockade compared to naltrexone. Additionally, buprenorphine's partial opioid agonist activity could theoretically interfere with the extinction of alcohol reward. For people with alcohol use disorder alone, naltrexone, acamprosate, or disulfiram are the evidence-based medication options.

When Both Alcohol and Opioid Disorders Are Present

For individuals with co-occurring alcohol and opioid use disorders, treatment planning becomes more complex. Suboxone may be appropriate for the opioid component while a separate medication (such as acamprosate or disulfiram) addresses the alcohol component. Some clinicians use naltrexone (either oral or injectable Vivitrol) to treat both conditions simultaneously, as naltrexone has FDA approval for both opioid and alcohol use disorders. This decision should be made by an addiction medicine specialist who can evaluate the severity of each condition and tailor treatment accordingly.

FDA-Approved Medications for Alcohol Use Disorder

• •Naltrexone (ReVia, Vivitrol) — blocks opioid receptors, reduces cravings and the rewarding effects of alcohol
• •Acamprosate (Campral) — restores brain chemistry balance disrupted by chronic alcohol use, reduces emotional distress of abstinence
• •Disulfiram (Antabuse) — causes unpleasant physical reactions if alcohol is consumed, serving as a deterrent

The Importance of Professional Guidance

Self-medicating with Suboxone for alcohol problems is dangerous and ineffective. If you are struggling with alcohol use disorder, speak with an addiction medicine specialist about FDA-approved treatment options. If you have both alcohol and opioid dependencies, integrated treatment that addresses both conditions with appropriate medications and therapy offers the best outcomes. The treatment landscape for substance use disorders has advanced significantly, and evidence-based options are available for virtually every clinical scenario.

Related Resources